1. Home
  2. PSN vs HALO Comparison

PSN vs HALO Comparison

Compare PSN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$65.71

Market Cap

6.6B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$75.09

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
HALO
Founded
1944
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.4B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PSN
HALO
Price
$65.71
$75.09
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$84.93
$73.33
AVG Volume (30 Days)
1.8M
2.2M
Earning Date
02-18-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
7.02
56.68
EPS
2.17
4.74
Revenue
$6,494,748,000.00
$1,242,852,000.00
Revenue This Year
N/A
$34.83
Revenue Next Year
$4.29
$24.84
P/E Ratio
$30.37
$15.44
Revenue Growth
N/A
31.19
52 Week Low
$54.56
$47.50
52 Week High
$97.91
$79.50

Technical Indicators

Market Signals
Indicator
PSN
HALO
Relative Strength Index (RSI) 44.87 72.04
Support Level $61.56 $67.02
Resistance Level $67.11 $69.48
Average True Range (ATR) 1.56 1.85
MACD 1.15 0.92
Stochastic Oscillator 80.38 91.07

Price Performance

Historical Comparison
PSN
HALO

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: